Resultados de la búsqueda 281-290 of 12795 for treatment resistant depression
Ascorbic Acid And Chemotherapy For The Treatment Of Relapsed Or Refractory Lymphoma, CCUS, And Chronic Myelomonocytic Leukemia ... Resistant To Current Standard ...
... therapy, but this study will administer treatment in approximately 3 weeks. ... treated with ALL therapy ... resistant chronic lymphocytic leukemia. Patients ...
... refractory (R/R) MM. ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step ...
... resistant prostate cancer (mCRPC) who have received prior anti-cancer treatment and have a positive 68Ga-PSMA-11 PET scan. The purpose of this study is to ...
Percentage of screened subjects experiencing loss of heterozygosity of HLA-A*02. Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic ...
Ascorbic Acid And Chemotherapy For The Treatment Of Relapsed Or Refractory Lymphoma, CCUS, And Chronic Myelomonocytic Leukemia. Rochester, Minn., Mankato ...
Even though the number of cell therapy clinical trials for CHD has increased in the last decade, more long-term follow-up studies are needed in this population ...
... treating patients with B-cell non-Hodgkin lymphoma that has returned (recurrent) or did not respond to treatment (refractory). Monoclonal antibodies, such ...
A Study Of An MMSET Inhibitor In Patients With Relapsed And Refractory Multiple Myeloma. Jacksonville, Fla., Rochester, Minn., Scottsdale/Phoenix, Ariz. A Phase ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?